AstraZeneca hit by lung cancer drug setback: Pharma giant halts trials of experimental Volrustomig treatment
Astra said its Volrustomig treatment, when combined with chemotherapy, was unlikely to help lung cancer patients live longer than rival offerings.
We haven't written up this one. This Is Money has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.